Bevacizumab 400mg/16mL (25mg/mL) Injection

Bevacizumab 400mg/16mL (25mg/mL) is an anti-angiogenic antibody used in selected cancer regimens. It targets the blood-vessel growth that helps tumours obtain oxygen and nutrients.
It is diluted for intravenous infusion. The initial infusion is given slowly, with later infusions shortened only if the earlier infusion was well tolerated.
Bevacizumab binds vascular endothelial growth factor, preventing it from activating receptors that stimulate new blood-vessel formation.
High blood pressure, tiredness, headache, protein in urine and minor bleeding can occur. Major bleeding, impaired wound healing, thrombosis and bowel perforation are serious risks.
Blood pressure and urine protein are monitored. Planned surgery requires a treatment pause and assessment of wound healing before therapy resumes.
Can slow tumour progression by restricting new blood-vessel growth, often alongside other anticancer treatment.
Protein leakage can indicate an effect on the kidney's filtering system.
Blocking blood-vessel growth can impair healing, so doses are separated from major surgery.
Minor bleeding can occur, but persistent bleeding, coughing blood or black stools needs prompt attention.
No. It mainly targets the tumour's blood-vessel signalling rather than directly blocking cell division.
VEGF: a protein that stimulates blood-vessel growth. Angiogenesis: formation of new blood vessels. Proteinuria: excess protein in urine.; AR: Bevacizumab 400mg/16mL (25mg/mL) حقن; FR: Bevacizumab 400mg/16mL (25mg/mL) injection; PT: Bevacizumab 400mg/16mL (25mg/mL) injeção; ES: Bevacizumab 400mg/16mL (25mg/mL) inyección; RU: Bevacizumab 400mg/16mL (25mg/mL) инъекция; ID: Bevacizumab 400mg/16mL (25mg/mL) injeksi; VI: Bevacizumab 400mg/16mL (25mg/mL) thuốc tiêm; MS: Bevacizumab 400mg/16mL (25mg/mL) suntikan; TL: Bevacizumab 400mg/16mL (25mg/mL) iniksyon; ZH-SG: Bevacizumab 400mg/16mL (25mg/mL) 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Bevacizumab 400mg/16mL (25mg/mL) Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Bevacizumab 400mg/16mL (25mg/mL) Injection